Beyond the Market View: Unlocking Granular Patient and Provider Intelligence
A National Living Lab of EHR-Sourced Data, providing your internal analytics team with unparalleled visibility and actionable intelligence across the entire GLP-1 product lifecycle.
Competitive Intelligence
- Real-world U.S. market share dynamics
- Head-to-head effectiveness comparisons
- Prescriber switching patterns
- Treatment optimization strategies
- Market penetration insights
Regulatory Acceleration
- FDA-grade data quality standards
- Post-market surveillance capabilities
- Comparative effectiveness evidence
- Safety signal detection
- Label expansion support
Market Access Optimization
- Provider decision intelligence
- Health economics outcomes research
- Payer negotiation evidence
- Cost-effectiveness modeling
- Value-based contracting support
Clinical Development Precision
- Patient population characterization
- Clinical trial design optimization
- Biomarker discovery opportunities
- Endpoint selection guidance
- Risk stratification models
OBSURV AI: A Deeper Understanding of Patient and Provider Behavior that Only AI-Ready Clinical Notes Can Uncover
What if you could understand the why behind every GLP-1 decision?
OBSURV RWE AI-ready clinical notes empower your data scientists to deploy verified Large Language Models (LLMs) prompts, unlocking unique insights from clinical notes that claims and structured EHR data can’t touch.
Decision Driver Analysis
Understand exactly why doctors start, continue, switch, or stop GLP-1 therapies by patient type.
Symptom & Trajectory Mapping
Enrich your understanding of disease progression with clinician observations captured in notes.
Patient Reported Outcomes Monitoring
Gain deeper insights into patient challenges along their weight loss journeys.
Market-by-Market Insights
Pinpoint regional variations in GLP-1 prescribing preferences for hyper-targeted commercial strategies.
LLM – Ready Clinical Notes
de-identified, longitudinal, and unmatched depth:
- Chief Complaint
- Past Medical History
- Review of Symptoms
- Current Medications
- Physical Exam
- Patient Assessment
- Recommendation
- Treatment Plan
LLM – Ready Clinical Notes
de-identified, longitudinal, and unmatched depth:
- Chief Complaint
- Past Medical History
- Review of Symptoms
- Current Medications
- Physical Exam
- Patient Assessment
- Recommendation
- Treatment Plan
OBSURV AI: A Deeper Understanding of Patient and Provider Behavior that Only AI-Ready Clinical Notes Can Uncover
What if you could understand the why behind every GLP-1 decision?
OBSURV RWE AI-ready clinical notes empower your data scientists to deploy verified Large Language Models (LLMs), unlocking unique insights from clinical notes that claims and structured EHR data can’t touch.
- Decision Driver Analysis: Understand exactly why doctors start, continue, switch, or stop GLP-1 therapies by specialty and patient type
- Symptom & Trajectory Mapping: Enrich your understanding of disease progression with clinician observations captured in notes.
- Patient Reported Outcomes Monitoring: Gain deeper insights into patient challenges along their weight loss journeys.
- Market-by-Market Insights: Pinpoint regional variations in GLP-1 prescribing preferences for hyper-targeted commercial strategies.
A New Standard in RWE Quality ... Delivered to Your GLP-1 Evidence Platform
Gain unparalleled market intelligence and a deeper understanding of patient and provider behavior across the US obesity market.